Drug
Nusivertib
Nusivertib: highest development phase Phase 1/2, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nusivertib NCT04176198 | Phase 1/2 | Myelofibrosis |
Latest
No recent events.
Follow Nusivertib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.